Detail akcie Brainsway online

Business Summary: Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system is used in various clinical applications, including major depression, bi-polar disorders, obesity, eating disorders, schizophrenia, Parkinson's disease, Altzheimer's disease, stroke rehabilitation, post-traumatic stress disorder, chronic pain, drug addiction, smoking cessation, epilepsy, migraine, tourette syndrome, uncontrolled blinking, autism, and multiple sclerosis.
Financial Summary: BRIEF: For the six months ended 30 June 2019, Brainsway Ltd revenues increased 48% to $10.9M. Net loss increased 89% to $5.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling & Marketing Expenses increase of 61% to $6.1M (expense), Research & Development Expenses increase of 39% to $4.2M (expense).